We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
3176
Voyager Therapeutics
VYGR
$198M
$96K ﹤0.01%
9,022
+4,871
+117% +$57.2K
XOMA
3177
DELISTED
Xoma
XOMA
$96K ﹤0.01%
5,092
+2,172
+74% +$40.7K
PCTI
3178
DELISTED
PCTEL, Inc. Common Stock
PCTI
$96K ﹤0.01%
16,919
-157
-0.9% -$982
TPTX
3179
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$96K ﹤0.01%
1,096
-4,041
-79% -$282K
PRVL
3180
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$96K ﹤0.01%
9,468
+5,241
+124% +$70.3K
PFSW
3181
DELISTED
PFSweb, Inc.
PFSW
$96K ﹤0.01%
14,321
+13,628
+1,967% +$101K
ACWX icon
3182
iShares MSCI ACWI ex US ETF
ACWX
$12B
$95K ﹤0.01%
2,062
+862
+72% +$39.7K
HALO icon
3183
Halozyme
HALO
$11.2B
$95K ﹤0.01%
3,617
-16,875
-82% -$470K
NKTR icon
3184
Nektar Therapeutics
NKTR
$2.54B
$95K ﹤0.01%
380
-3,413
-90% -$1.07M
TTD icon
3185
Trade Desk
TTD
$6.6B
$95K ﹤0.01%
1,830
-51,740
-97% -$2.36M
MFC icon
3186
Manulife Financial
MFC
$73.6B
$94K ﹤0.01%
+6,764
New +$96.9K
RRC icon
3187
Range Resources
RRC
$9.43B
$94K ﹤0.01%
14,217
-4,947
-26% -$35.8K
SLNO
3188
DELISTED
Soleno Therapeutics
SLNO
$94K ﹤0.01%
2,492
+2,091
+521% +$61.1K
LEVL
3189
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$94K ﹤0.01%
6,010
+3,852
+178% +$62.8K
AMR icon
3190
Alpha Metallurgical Resources
AMR
$2.08B
$93K ﹤0.01%
12,696
-5,702
-31% -$26.5K
BG icon
3191
Bunge Global
BG
$21.8B
$93K ﹤0.01%
2,042
-1,058
-34% -$47.3K
CBAN icon
3192
Colony Bankcorp
CBAN
$471M
$93K ﹤0.01%
8,615
+6,575
+322% +$70.7K
CDTX
3193
DELISTED
Cidara Therapeutics
CDTX
$93K ﹤0.01%
1,640
+262
+19% +$18.5K
DRIP icon
3194
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$99.1M
$93K ﹤0.01%
13
-506
-97% -$2.77M
ELME
3195
Elme Communities
ELME
$144M
$93K ﹤0.01%
4,622
-885
-16% -$19.3K
FBK icon
3196
FB Financial Corp
FBK
$3.1B
$93K ﹤0.01%
3,692
+1,781
+93% +$46.1K
GNPX icon
3197
Genprex
GNPX
$2.24M
$93K ﹤0.01%
+1
New +$158K
LEVI icon
3198
Levi Strauss
LEVI
$8.6B
$93K ﹤0.01%
6,943
-5,048
-42% -$64.1K
PSTL
3199
Postal Realty Trust
PSTL
$697M
$93K ﹤0.01%
6,125
+4,852
+381% +$71.7K
ALR
3200
DELISTED
AlerisLife Inc
ALR
$93K ﹤0.01%
18,316
+4,516
+33% +$21.5K
126 127
128
129 130

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.